z-logo
open-access-imgOpen Access
[Corrigendum] Lapatinib‑induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro
Author(s) -
Qiuyue Liao,
Xue Feng,
Xi Li,
Ge Chen,
Jing Chen,
Bin Yang,
Kezhen Li,
Jihui Ai
Publication year - 2021
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2021.8074
Subject(s) - oncogene , in vivo , in vitro , lapatinib , audience measurement , function (biology) , oncology , medicine , cancer research , psychology , biology , cancer , cell cycle , genetics , law , trastuzumab , breast cancer , political science
Following the publication of the above article, the authors have realized that the same image had been selected to show H&E staining of the ovarian slices in the Control and 10 μM groups in Fig. 4A. After reviewing the original pictures, the authors discovered that the image correctly showing the data for the 48 h, 10 μM group had also been used for the 48 h Control group. The corrected version of Fig. 4, showing the correct data for the 48 h Control group in Fig. 4A, is shown below. It should be noted that the inadvertent error that occurred during the compilation of this figure did not affect the results or the conclusions of this article. The authors all agree to this Corrigendum, and are grateful to the Editor of Oncology Reports for granting them the opportunity to correct this figure. The authors also apologize to the readership for any inconvenience caused. [the original article was published in Oncology Reports 44: 1127‑1135, 2020; DOI: 10.3892/or.2020.7660].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom